AAAAAA

   
Results: 1-16 |
Results: 16
BUSPIRONE PLASMA-CONCENTRATIONS
Authors: BARBANOJ MJ PARRA P JANE F
Citation: Mj. Barbanoj et al., BUSPIRONE PLASMA-CONCENTRATIONS, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 347-347
NO SEX-RELATED PHARMACOKINETIC AND PHARMACODYNAMIC DIFFERENCES OF CAPTOPRIL
Authors: MASSANA E BARBANOJ MJ MOROS C MORTE A GICH I JANE F
Citation: E. Massana et al., NO SEX-RELATED PHARMACOKINETIC AND PHARMACODYNAMIC DIFFERENCES OF CAPTOPRIL, Pharmacological research, 36(1), 1997, pp. 41-47
BIOINVERSION OF R(-)-KETOPROFEN AFTER ORAL-ADMINISTRATION IN HEALTHY-VOLUNTEERS
Authors: GICH I BAYES M BARBANOJ MJ ARTIGAS R TOST D MAULEON D
Citation: I. Gich et al., BIOINVERSION OF R(-)-KETOPROFEN AFTER ORAL-ADMINISTRATION IN HEALTHY-VOLUNTEERS, Clinical drug investigation, 11(6), 1996, pp. 347-352
GROUNDS FOR THE INTEGRATION OF PHARMACOKINETIC-PHARMACODYNAMIC DATA
Authors: BARBANOJ MJ SALAZAR G MORTE A ANTONIJOAN RM GICH I JANE F
Citation: Mj. Barbanoj et al., GROUNDS FOR THE INTEGRATION OF PHARMACOKINETIC-PHARMACODYNAMIC DATA, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 43-45
PHARMACOKINETIC PROFILE OF AN ORAL MODIFIED-RELEASE MORPHINE FORMULATION, IN HEALTHY-YOUNG SUBJECTS OF BOTH SEXES
Authors: SALAZAR G GICH I ANTONIJOAN RM BARBANOJ MJ JANE F ARMARIO A
Citation: G. Salazar et al., PHARMACOKINETIC PROFILE OF AN ORAL MODIFIED-RELEASE MORPHINE FORMULATION, IN HEALTHY-YOUNG SUBJECTS OF BOTH SEXES, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 63-63
COMPARISON OF 2 METHODS TO ASSESS THE PERIPHERAL-DRUG ANTIHISTAMINIC ACTIVITY - SENSITIVITY AND REPRODUCIBILITY
Authors: ANTONIJOAN RM GARCIAGEA C MASSANA E MORTE A BARBANOJ MJ
Citation: Rm. Antonijoan et al., COMPARISON OF 2 METHODS TO ASSESS THE PERIPHERAL-DRUG ANTIHISTAMINIC ACTIVITY - SENSITIVITY AND REPRODUCIBILITY, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 65-65
BIOEQUIVALENCE TRIAL BETWEEN ORAL TABLET FORMULATIONS OF CAPTOPRIL, IN HEALTHY-SUBJECTS
Authors: GICH I MOROS C BAYES MC RODRIGUEZ M BARBANOJ MJ LOPEZ C DELGADILLO J
Citation: I. Gich et al., BIOEQUIVALENCE TRIAL BETWEEN ORAL TABLET FORMULATIONS OF CAPTOPRIL, IN HEALTHY-SUBJECTS, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 98-98
VIGILANCE EFFECTS AFTER AZASPIRONE AND BENZODIAZEPINE REPETITIVE TREATMENTS IN HEALTHY-SUBJECTS
Authors: GARCIAGEA C MORTE A ANTONIJOAN R BARBANOJ MJ JANE F
Citation: C. Garciagea et al., VIGILANCE EFFECTS AFTER AZASPIRONE AND BENZODIAZEPINE REPETITIVE TREATMENTS IN HEALTHY-SUBJECTS, Methods and findings in experimental and clinical pharmacology, 18, 1996, pp. 105-105
A DRUG-INTERACTION STUDY BETWEEN CICLETANINE AND TOLBUTAMIDE IN HEALTHY-VOLUNTEERS
Authors: BAYES MC BARBANOJ MJ VALLES J TORRENT J OBACH R JANE F
Citation: Mc. Bayes et al., A DRUG-INTERACTION STUDY BETWEEN CICLETANINE AND TOLBUTAMIDE IN HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 50(5), 1996, pp. 381-384
GENDER-RELATED PHARMACOKINETICS OF DILTIAZEM IN HEALTHY-SUBJECTS
Authors: SAENZCAMPOS D BAYES MC MARTIN S BARBANOJ MJ JANE F
Citation: D. Saenzcampos et al., GENDER-RELATED PHARMACOKINETICS OF DILTIAZEM IN HEALTHY-SUBJECTS, International journal of clinical pharmacology and therapeutics, 33(7), 1995, pp. 397-400
EVALUATION OF THE CENTRAL EFFECTS OF ALCOHOL AND CAFFEINE INTERACTION
Authors: AZCONA O BARBANOJ MJ TORRENT J JANE F
Citation: O. Azcona et al., EVALUATION OF THE CENTRAL EFFECTS OF ALCOHOL AND CAFFEINE INTERACTION, British journal of clinical pharmacology, 40(4), 1995, pp. 393-400
BUSPIRONE AND ELECTROENCEPHALOGRAPHY
Authors: BARBANOJ MJ ANTONIJOAN RM JANE F
Citation: Mj. Barbanoj et al., BUSPIRONE AND ELECTROENCEPHALOGRAPHY, Clinical pharmacology and therapeutics, 57(6), 1995, pp. 699-699
TOPOGRAPHIC PHARMACO-EEG MAPPING OF INCREASING DOSES OF BUSPIRONE ANDITS COMPARISON WITH DIAZEPAM
Authors: BARBANOJ MJ ANDERER P ANTONIJOAN RM TORRENT J SALETU B JANE F
Citation: Mj. Barbanoj et al., TOPOGRAPHIC PHARMACO-EEG MAPPING OF INCREASING DOSES OF BUSPIRONE ANDITS COMPARISON WITH DIAZEPAM, Human psychopharmacology, 9(2), 1994, pp. 101-109
CLINICAL-PHARMACOLOGICAL STUDY WITH THE 2 ISOMERS (D-FENFLURAMINE, L-FENFLURAMINE) OF FENFLURAMINE AND ITS COMPARISON WITH CHLORPROMAZINE AND D-AMPHETAMINE - BLOOD-LEVELS, EEG MAPPING AND SAFETY EVALUATION
Authors: SALETU B BARBANOJ MJ ANDERER P SIEGHART W GRUNBERGER J
Citation: B. Saletu et al., CLINICAL-PHARMACOLOGICAL STUDY WITH THE 2 ISOMERS (D-FENFLURAMINE, L-FENFLURAMINE) OF FENFLURAMINE AND ITS COMPARISON WITH CHLORPROMAZINE AND D-AMPHETAMINE - BLOOD-LEVELS, EEG MAPPING AND SAFETY EVALUATION, Methods and findings in experimental and clinical pharmacology, 15(5), 1993, pp. 291-312
CLINICAL-PHARMACOLOGICAL STUDY WITH THE 2 ISOMERS (D-FENFLURAMINE, L-FENFLURAMINE) OF FENFLURAMINE AND ITS COMPARISON WITH CHLORPROMAZINE AND D-AMPHETAMINE - PSYCHOMETRIC AND PSYCHOPHYSIOLOGICAL EVALUATION
Authors: GRUNBERGER J SALETU B LINZMAYER L BARBANOJ MJ
Citation: J. Grunberger et al., CLINICAL-PHARMACOLOGICAL STUDY WITH THE 2 ISOMERS (D-FENFLURAMINE, L-FENFLURAMINE) OF FENFLURAMINE AND ITS COMPARISON WITH CHLORPROMAZINE AND D-AMPHETAMINE - PSYCHOMETRIC AND PSYCHOPHYSIOLOGICAL EVALUATION, Methods and findings in experimental and clinical pharmacology, 15(5), 1993, pp. 313-328
RESTRICTION TO A LIMITED SET OF EEG-TARGET VARIABLES MAY LEAD TO MISINTERPRETATION OF PHARMACO-EEG RESULTS
Authors: ANDERER P BARBANOJ MJ SALETU B SEMLITSCH HV
Citation: P. Anderer et al., RESTRICTION TO A LIMITED SET OF EEG-TARGET VARIABLES MAY LEAD TO MISINTERPRETATION OF PHARMACO-EEG RESULTS, Neuropsychobiology, 27(2), 1993, pp. 112
Risultati: 1-16 |